483 Abraxis Bioscience Feb 2020

483 Abraxis Bioscience Feb 2020

Carrie Hughes FDA$119.00 - Available Now

FDA investigators audited the Abraxis Bioscience - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 19 Feb 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Feb 2020
  • Location: Phoenix, United States
  • FEI: 3006441852
Add To Cart